Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Shree Ganesh Remedies Ltd has witnessed a significant shift in its valuation parameters, moving from an already expensive rating to a very expensive classification, even as its stock price surged by over 13% in a single day. This article analyses the evolving price attractiveness of the micro-cap pharmaceutical player in the context of its historical metrics, peer comparisons, and broader market performance.

At Rs 651.10, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Shree Ganesh Remedies Ltd locked at its upper circuit of 20% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in price momentum, moving from a sideways trend to a mildly bullish stance. Despite mixed signals from key technical indicators such as MACD, RSI, and Bollinger Bands, the stock’s recent 5.07% day gain and a 7.62% weekly return outperforming the Sensex suggest cautious optimism among investors.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest day gain of 2.19% to close at ₹517.30, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Strong Sell to Sell, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages. This article analyses these technical parameters in detail, alongside the stock’s recent price action and comparative returns against the Sensex.

Shree Ganesh Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 17 August 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a robust day change of 6.65%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, challenging investors to carefully analyse its near-term trajectory.

Shree Ganesh Remedies Ltd has been downgraded from a Sell to a Strong Sell rating following a sharp deterioration in its financial performance and a shift towards bearish technical indicators. The pharmaceutical micro-cap’s recent quarterly results reveal significant declines in profitability and operational efficiency, while technical trends signal growing investor caution. This comprehensive analysis explores the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that have driven the rating change as of 13 August 2026.

Shree Ganesh Remedies Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bullish to mildly bearish trends. The stock’s recent 12.61% decline and downgrading to a Strong Sell rating reflect growing investor caution amid mixed technical signals and subdued price action.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a recent downgrade in daily price performance, the stock’s longer-term returns continue to outpace the Sensex, underscoring a nuanced investment landscape for traders and investors alike.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently exhibited a notable shift in its technical momentum, upgrading its MarketsMOJO grade from Sell to Hold. This change reflects improving price action and technical indicators, signalling a cautiously optimistic outlook despite broader sector headwinds and mixed market returns.

Shree Ganesh Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent day decline of 3.62%, the stock’s year-to-date return of 34.38% significantly outpaces the Sensex’s negative 7.97%, reflecting underlying resilience amid mixed technical signals.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, upgrading its MarketsMOJO grade from Sell to Hold as of 20 May 2026. The stock’s recent price action and technical indicators suggest a transition from a mildly bullish to a more confident bullish trend, signalling potential opportunities for investors amid a mixed broader market backdrop.

Shree Ganesh Remedies Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of early August 2026. Despite a recent downgrade in daily price performance, the stock’s mixed signals from key technical indicators such as MACD, RSI, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish trend. This change is underpinned by strong signals from key technical indicators such as MACD, Bollinger Bands, and moving averages, signalling renewed investor interest and potential for further price appreciation.